At Medicover Integrated Clinical Services (MICS), we understand the pivotal role that reliable and compliant genomic assays play in the success of clinical trials. Our commitment to excellence in developing quantitative Polymerase Chain Reaction (qPCR) and droplet digital PCR (ddPCR) assays is unmatched, especially under the stringent requirements of the In Vitro Diagnostic Regulation (IVDR) in the European Union. Here’s why pharmaceutical companies and biotech firms choose us as their trusted partner in establishing qPCR assays for clinical trials.
Experts in Assay Development and Validation
Custom Assay Design and Optimization
We have the ability to design and optimize qPCR and ddPCR assays tailored to the unique needs of your clinical trials. Our team of experts selects primers and probes, optimizes reaction conditions, and ensures that our assays are both sensitive and specific to your target genetic material. Our approach in precision medicine guarantees the development of robust assays that deliver accurate and reproducible results.
Validation According to IVDR Standards
Our stringent validation process ensures that all qPCR and ddPCR assays meet the rigorous standards set by the IVDR. We conduct comprehensive validation studies to demonstrate assay performance characteristics such as accuracy, precision, specificity, sensitivity, and reproducibility. By doing so, we provide you with confidence that our assays are reliable and compliant with regulatory expectations.
Ensuring Regulatory Compliance
Comprehensive Documentation
IVDR compliance demands thorough and meticulous documentation. We provide detailed protocols, validation reports, and quality control measures, ensuring that every step of the assay development process is transparent and verifiable. Our comprehensive documentation is designed to support your regulatory submissions and audits, facilitating a smooth approval process.
Regulatory Submission Support
Navigating the regulatory landscape can be complex, but our dedicated regulatory experts are here to help. We assist in preparing and submitting all necessary documentation to regulatory bodies, including technical files, risk assessments, and performance evaluation reports required by the IVDR. Our expertise ensures that your submissions are thorough and timely.
Leveraging Advanced Technologies
State-of-the-Art Equipment and Facilities
Our laboratory is equipped with cutting-edge technologies essential for high-quality qPCR and ddPCR assay development. With advanced thermal cyclers, real-time PCR machines, and automated liquid handling systems, we ensure precision and efficiency in every assay we develop. Our state-of-the-art facilities enable us to deliver high-throughput and highly accurate assays that meet your needs..
Collaborative and Continuous Support
Collaborative Development Process
We believe in a collaborative approach to assay development. By working closely with your team, we ensure that our qPCR assays align perfectly with your specific requirements and challenges. Through regular updates, consultations, and iterative feedback loops, we ensure that our development process is transparent and meets your objectives and regulatory standards.
Ongoing Post-Development Support
Our commitment to your success extends beyond assay development. We offer continuous support, including troubleshooting, assay refinement, and training, ensuring that our qPCR assays perform optimally throughout your clinical trials. This ongoing support is essential for maintaining the integrity and reliability of the assays over time.
Partner with MICS for reliable, compliant qPCR assays that comply with IVDR regulation.
How can MICS support pharma companies with IVDR-conform qPCR assays?
At MICS, we specialize in developing and validating IVDR-compliant qPCR assays tailored to the needs of pharmaceutical companies. Our expertise includes:
- Custom Assay Design: We design and optimize qPCR assays specific to your clinical trial requirements, ensuring high sensitivity and specificity.
- IVDR Validation: We conduct comprehensive validation studies to meet IVDR standards, covering accuracy, precision, specificity, sensitivity, and reproducibility.
- Regulatory Support: Our team assists with the preparation and submission of all necessary documentation to regulatory bodies, ensuring a smooth approval process.
- Advanced Technology: Our state-of-the-art facilities and equipment ensure precise and efficient assay development.
- Bioinformatics: We provide robust bioinformatics support to analyze and interpret assay data, transforming it into actionable insights.
- Continuous Support: We offer ongoing assistance, including troubleshooting, assay refinement, and training for your team, ensuring optimal performance throughout your clinical trials.
FAQ about qPCR and IVDR
1. What is qPCR and why is it important in clinical trials?
Quantitative PCR (qPCR) is a laboratory technique that amplifies and quantifies specific DNA fragments. It’s essential for detecting genetic biomarkers, monitoring therapeutic response, and supporting precision medicine approaches in clinical trials.
2. What is the IVDR and how does it impact qPCR assays?
The In Vitro Diagnostic Regulation (IVDR) is the EU regulatory framework governing diagnostic tests. It requires strict validation of analytical performance, documentation, risk assessment, and post-market surveillance for any assay used in clinical settings, including qPCR.
3. What performance characteristics must be validated under IVDR?
Common parameters include: Accuracy, Precision, Sensitivity, Specificity, Limit of detection, Reproducibility. Demonstrating these ensures clinical reliability and regulatory compliance.
4. What documentation is required for IVDR-compliant assay submissions?
Typical documentation includes: Technical files, Validation reports, Risk management documentation, Performance evaluation plans, Quality control procedures. These are used during regulatory audits and approvals.
5. How does ddPCR differ from qPCR?
Droplet digital PCR (ddPCR) partitions the sample into thousands of droplets and allows absolute quantification without relying on standard curves. It offers higher sensitivity for low-abundance targets, making it useful for rare variant detection.
6. Why should pharma companies outsource IVDR-compliant assay development?
Specialist laboratories provide:
– Regulatory expertise
– Qualified bioinformatics support
– State-of-the-art equipment
– Validation experience
– Comprehensive documentation
This minimizes compliance risks and accelerates timelines.
References
- Structure and content of the EU-IVDR (In Vitro Diagnostic Regulation), PMC / NCBI, Accessed: 21 October 2025.
- Droplet Digital PCR (ddPCR) Technology – Introduction, Bio-Rad Laboratories, Accessed: 21 October 2025.
- EU Regulation: Overview of New Medical Device & IVD Regulations, European Commission, Accessed: 21 October 2025
***
Author: MICS Editorial Team
Published Date: June 2024
